Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
February 14th, 2022
Anteris Technologies Declines Merger Proposal
Read More
February 14th, 2022
Why Horizon 3 Biotech Investment Committee like EBR Systems
Read More
January 28th, 2022
Cogstate - US$13.7 Million of Sales Contracts Signed
Read More
July 27th, 2021
Adalta Moves to Inhaled Delivery for AD-214
Read More
June 15th, 2021
Adalta Progresses GE Collaboration and Sets Clear Milestones for Path Ahead
Read More
March 15th, 2021
Adalta Phase Ia Results – Multiple Positive Findings
Read More
February 15th, 2021
Adalta’s Prospects Improve
Read More
Pages
1
2
3
4
5
6
7
8
9
